Myriad Genetics: TD Cowen raises target price to $4.5 from $4
MYGN•TD Cowen raised its target price for Myriad Genetics to $4.5 from $4.
Related News
Lazard, Inc.: Goldman Sachs cuts target price to $32 from $36
LAZ•
Vital Farms Inc: TD Cowen cuts target price to $8 from $11
VITL•
Dolphin Entertainment CEO William O'Dowd IV buys $4,784 of common shares
DLPN•
JPMorgan hit by slowdown in investment banking momentum, shares slip
JPM•
Truist Securities raises VF Corp to buy from hold, lifts target price to $20 from $14
VFC•